Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Qiming U.S. Healthcare Fund II, L.P.
10% owner at Jasper Therapeutics. Filing since 27 Jan 2023.
CIK 0001765710
Company
Date
Role
Action
Shares
Amount
Of holding
JSPR
Jasper Therapeutics, Inc.
27 Jan 2023
10% owner
Bought
2,666,666
$4.00M
45.6%
1 decision on file.